Comments
Loading...

Intensity Therapeutics Earnings Estimates

INTSNASDAQ
Logo brought to you by Benzinga Data
$2.04
0.010.49%
At close: -
$2.09
0.052.57%
After Hours: 6:46 PM EDT

Intensity Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:INTS | Benzinga

Intensity Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
May 8
EPS Estimate
$-0.280
Quarterly Revenue Estimate
Annual Revenue
(as of Dec 31)

Analyze the earnings history of Intensity Therapeutics using advanced sorting and filters.

Get Alert
INTSIntensity Therapeutics-$0.34-$0.28$0.0005/08/2025Get Alert
INTSIntensity Therapeutics-$0.12-$0.23-$0.224.35%$0.00$0.0003/13/2025Get Alert
INTSIntensity Therapeutics-$0.17-$0.30-$0.2516.67%$0.00$0.0011/13/2024Get Alert
INTSIntensity Therapeutics-$1.43-$0.32-$0.36-12.50%$0.00$0.0008/08/2024Get Alert
INTSIntensity Therapeutics-$0.39-$0.34$0.0005/09/2024Get Alert
INTSIntensity Therapeutics-$0.18-$0.1233.33%$0.0003/14/2024Get Alert
INTSIntensity Therapeutics-$0.52-$0.09-$0.17-88.89%$0.00$0.0011/13/2023Get Alert
INTSIntensity Therapeutics-$0.40-$0.79-97.50%$0.00$0.0008/14/2023Get Alert

Intensity Therapeutics (INTS) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q42025-03-13$-0.22$-0.234.35 %
Q32024-11-13$-0.25$-0.3016.7 %
Q22024-08-08$-0.36$-0.32-12.5 %
Q42024-03-14$-0.12$-0.1833.3 %

Intensity Therapeutics (INTS) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Intensity Therapeutics (NASDAQ:INTS) reporting earnings?

A

Intensity Therapeutics (INTS) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 13, 2025 for Q4.

Q

What were the latest earnings per share (EPS) for Intensity Therapeutics (NASDAQ:INTS)?

A

The Actual EPS was $-0.22, which beat the estimate of $-0.23.

Q

What were Intensity Therapeutics’s (NASDAQ:INTS) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch